Page 200 - Guida alle Vaccinazioni
P. 200

91. Stone CA, Hemler JA, Cox ASJ et al. Anaphilaxis after zoster vaccine: Implicating alpha-gal allergy as a
possible meccanism. among children with cow’s milk allergy. J Allergy Clin Immunol 2016

92. Stone CA Jr, Hemler JA, Commins SP et al. Anaphylaxis after zoster vaccine: Implicating alpha-gal
allergy as a possible mechanism. J Allergy Clin Immunol. 2016 Dec 14. pii: S0091-6749(16)31455-5

93. Lauri E, Markowitz LE, Dunne EF, et al. Human Papillomavirus Vaccination Recommendations of the
Advisory Committee on Immunization Practices (ACIP) MMWR RR / Vol. 63 / No. 5: 1-29

https://www.cdc.gov/mmwr/pdf/rr/rr6305.pdf
94. Badiu I’M, Geuna M, Heffler F and Rolla G. Hypersensitivity reaction to human papilloma virus vaccine
due to polysorbate 80. BMJ Case Rep. 2012 May 8;2012.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351639/

95. Kattan ID, Konstantinou GN, Cox AI et al. Anaphylaxis to diphtheria, tetanus, and pertussis vaccines
among children with cow's milk allergy. J Allergy Clin Immunol 2011; 128:215-8.
96. Ministero della Salute. Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2016-
2017. Circolare del 4 agosto 2016.

http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=265
4

97. Bergfors E, Hermansson G, Nyström Kronander U et al. How common are longlasting, intensely itching
vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? Eur
J Pediatr 2014 173:1297–1307.

98. Vogt T, Landthaler M and Stolz W. Generalized eczema in an 18-month-old boy due to phenoxyethano
in DPT vaccine. Contact Dermatitis. 1998 Jan;38(1):50-1.

99. Aguilar C, Malphettes M, Donadieu J et al. Prevention of Infections During Primary Immunodeficiency.
CID 2014:59(19): 1462-70.

100. Shearer WT, Fleisher TA, Buckley RH, et al. Medical Advisory Committee of the Immune Deficiency
Foundation. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their
close contacts. J Allergy Clin Immunol 2014; 133:961–6.
101. Sobh A and Bonilia FA. “Vaccination in Primary immunodeficiency disorders”. J Allergy Clin. Immunol.
Pract. 2016; 4:1066-75.

102. Reef SE and Plotkin SA. Rubella vaccine. Vaccines 6^ edizione a cura di Plotkin SA, Orestein WA and
Offit PA. Edizioni Elselver 2012 (31) 688-717.

103. Eibl MM and Wolf HM. Vaccination in patients with primary immune deficiency, secondary immune
deficiency and autoimmunity with immune regulatory abnormalities. Immunotherapy (2015) 7(12), 1273–
1292.
104. World Health Organization. Global Advisory Committee on Vaccine Safety,16–17 June 2010. WER
2010; 85: 285–290.

http://www.who.int/vaccine_safety/wer2010_wer8530.pdf

105. Centers for Disease Control and Prevention. Health Information for International Travel, 2016 Yellow
Book. Ed. Oxford press 2016

http://wwwn.cdc.gov/travel/contentYellowBook.aspx

106. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable
Diseases: The Pink Book Supplement 2017

https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/table-of-contents.pdf

                                                                                                                     200
   195   196   197   198   199   200   201   202   203   204   205